A detailed history of Stance Capital LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Stance Capital LLC holds 41,897 shares of BSX stock, worth $4.36 Million. This represents 3.12% of its overall portfolio holdings.

Number of Shares
41,897
Previous 47,255 11.34%
Holding current value
$4.36 Million
Previous $4.22 Billion 0.14%
% of portfolio
3.12%
Previous 2.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 16, 2025

SELL
$89.38 - $106.18 $478,898 - $568,912
-5,358 Reduced 11.34%
41,897 $4.23 Billion
Q4 2024

Apr 14, 2025

BUY
$83.62 - $91.5 $3.95 Million - $4.32 Million
47,255 New
47,255 $4.22 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $149B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Stance Capital LLC Portfolio

Follow Stance Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stance Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stance Capital LLC with notifications on news.